Loading company…
Okeiro provides an AI platform for transplant and chronic disease management and clinical research.
Okeiro offers an AI-powered precision medicine platform for monitoring and managing transplant and chronic disease patients. It supports remote monitoring, predictive algorithms and biomarker analysis, and its iBox model has been qualified by the EMA and FDA. Founded in 2023, the company is based in Paris, France. In April 2025, it raised EUR 10 million co-led by Alven, Red River West and Forepont Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in